{
  "zip": "30339",
  "sector": "Healthcare",
  "fullTimeEmployees": 2,
  "longBusinessSummary": "Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease, and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a c-Abl protein kinase inhibitor for use in the treatment of Parkinson's Disease, dysphagia, and neurogenic constipation; and IkT-001Pro, a prodrug of the anti-cancer agent Imatinib that is in preclinical development to minimize gastrointestinal side effects. It offers products comprise IkT-01427, a product candidate that blocks the causative virus of progressive multifocal leukoencephalopathy from replicating in the body; and IkT-148x series of portfolio compounds for use in the treatment of Dementia with Lewy Body and Multiple System Atrophy. The company was founded in 2008 and is headquartered in Atlanta, Georgia.",
  "city": "Atlanta",
  "phone": "678 392 3419",
  "state": "GA",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.inhibikase.com",
  "maxAge": 1,
  "address1": "3350 Riverwood Parkway",
  "industry": "Biotechnology",
  "address2": "Suite 1900",
  "previousClose": 7.1,
  "regularMarketOpen": 7.03,
  "twoHundredDayAverage": 7.7353334,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 7.0859,
  "navPrice": null,
  "averageDailyVolume10Day": 154462,
  "totalAssets": null,
  "regularMarketPreviousClose": 7.1,
  "fiftyDayAverage": 7.7353334,
  "trailingAnnualDividendRate": null,
  "open": 7.03,
  "averageVolume10days": 154462,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": null,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 6.62,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 108486,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 69049800,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 684653,
  "priceToSalesTrailing12Months": 89.87021,
  "dayLow": 6.62,
  "ask": 6.84,
  "ytdReturn": null,
  "askSize": 800,
  "volume": 108486,
  "fiftyTwoWeekHigh": 11.8,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 6.42,
  "bid": 6.62,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 800,
  "dayHigh": 7.0859,
  "exchange": "NMS",
  "shortName": "Inhibikase Therapeutics, Inc.",
  "longName": "Inhibikase Therapeutics, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "IKT",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_113910012",
  "uuid": "df2742fe-620d-3418-ba9f-016d7a873d41",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 76.003,
  "beta3Year": null,
  "profitMargins": -2.69406,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 10095000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": 23214,
  "sharesPercentSharesOut": 0.0023,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.14288001,
  "netIncomeToCommon": -2069918,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.51956004,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": 0.02,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 3852064,
  "enterpriseValue": 58395304,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1609372800,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": 0.0047999998,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 7.03,
  "logo_url": "https://logo.clearbit.com/inhibikase.com"
}